National Veterinary Associates Appoints Leslie Storms as President, Ethos Veterinary Health

National Veterinary Associates (NVA) today announced that Leslie Storms has been appointed President, Ethos Veterinary Health, effective immediately. She will also become an investor in the company. Ethos Veterinary Health is NVA's premier network of specialty and emergency care, comprised of over 140 hospitals and 1,500 team members across North America. https://mma.prnewswire.com/media/2835115/National_Veterinary_Associates__Leslie_Storms.jpg Storms will report […]

Mazda Partners with DonorsChoose to Help Students Discover their STEM Passions this Holiday Season

$250,000 Initiative Will Clear Teacher Lists Across U.S. Through Flash Fund and Matched Donations In honor of Giving Tuesday, Mazda North American Operations, in partnership with education non-profit DonorsChoose, is kicking off the holiday season with a $250,000 donation to uplift students and teachers across the country. The collaborative effort aims to provide dedicated educators,

Raindrop Raises $15 Million to Detect Critical AI Agent Failures

“Like Sentry, but for AI Agents” – Funding led by Lightspeed Venture Partners will enable Raindrop to meet enterprise demand and become the default monitoring solution for AI agents. Raindrop, the monitoring platform for AI agents, announced $15M in seed funding led by Lightspeed Venture Partners. The funding will enable Raindrop to meet enterprise demand,

Alan Mruvka’s VERZA TV to Launch With 80 Original Titles — Becoming the First U.S.-Based Vertical Micro-Drama App

Media pioneer Alan Mruvka, the co-founder of E! Entertainment Television, today announced the official launch of VERZA TV, the first U.S.-based mobile app dedicated primarily to vertical micro-dramas. The platform debuts with an unprecedented 80 original titles, immediately positioning VERZA TV as the new leader in short-form, serialized, premium storytelling built exclusively for mobile-first audiences.

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer’s Disease

Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15 million Series A financing round. The financing was led

DoubleLine Opportunistic Credit Fund Declares December 2025 Distribution

TheDoubleLine Opportunistic Credit Fund (the “Fund”), which is traded on the New York Stock Exchange under the symbol DBL, this week declared a distribution of $0.11 per share for the month of December 2025. The distribution is subject to the following ex-dividend, record and payment dates set by the Fund's Board of Trustees. https://mma.prnewswire.com/media/752903/DoubleLine_Logo.jpg December

Thompson Thrift Announces the Development of Canopy Flats, a Luxury Multifamily Community near Kansas City

Thompson Thrift, a full-service real estate company and one of the nation's leading multifamily developers, today announced the start of construction on Canopy Flats, a Class A multifamily community located along Metcalf Avenue in Overland Park. https://mma.prnewswire.com/media/2645557/Thompson_Thrift_Top_Workplaces_2025_Logo.jpg “We're proud to expand our presence in the Kansas City area with a community that reflects our commitment

Stride, Inc. (LRN) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, all dates inclusive (the “Class Period”), have until January 12, 2026 to seek appointment as lead plaintiff of the Stride class action lawsuit. Captioned MacMahon v. Stride, Inc., No. 25-cv-02019

XENOVIEW(R) 3T coil passes Philips compatibility testing

(LSE:POLX), DURHAM, NC and LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) — Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (“MRI”) of the lungs, announces that its FDA-cleared XENOVIEW(R) 3T Chest Coil has successfully completed compatibility testing conducted by Philips (Philips Medical Systems Nederland B.V.) and is now confirmed

Scroll to Top